全文获取类型
收费全文 | 9262篇 |
免费 | 500篇 |
国内免费 | 88篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 167篇 |
妇产科学 | 39篇 |
基础医学 | 1338篇 |
口腔科学 | 15篇 |
临床医学 | 437篇 |
内科学 | 1002篇 |
皮肤病学 | 25篇 |
神经病学 | 71篇 |
特种医学 | 73篇 |
外科学 | 157篇 |
综合类 | 690篇 |
预防医学 | 5223篇 |
眼科学 | 12篇 |
药学 | 375篇 |
中国医学 | 142篇 |
肿瘤学 | 71篇 |
出版年
2024年 | 7篇 |
2023年 | 119篇 |
2022年 | 205篇 |
2021年 | 676篇 |
2020年 | 391篇 |
2019年 | 293篇 |
2018年 | 306篇 |
2017年 | 286篇 |
2016年 | 417篇 |
2015年 | 612篇 |
2014年 | 662篇 |
2013年 | 639篇 |
2012年 | 727篇 |
2011年 | 1032篇 |
2010年 | 944篇 |
2009年 | 592篇 |
2008年 | 220篇 |
2007年 | 234篇 |
2006年 | 215篇 |
2005年 | 195篇 |
2004年 | 168篇 |
2003年 | 127篇 |
2002年 | 96篇 |
2001年 | 101篇 |
2000年 | 64篇 |
1999年 | 58篇 |
1998年 | 59篇 |
1997年 | 55篇 |
1996年 | 35篇 |
1995年 | 40篇 |
1994年 | 41篇 |
1993年 | 30篇 |
1992年 | 19篇 |
1991年 | 15篇 |
1990年 | 18篇 |
1989年 | 19篇 |
1988年 | 6篇 |
1987年 | 16篇 |
1986年 | 14篇 |
1985年 | 22篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 13篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1975年 | 2篇 |
排序方式: 共有9850条查询结果,搜索用时 15 毫秒
91.
目的评估台州市2018/2019年度社区老年人接种三价灭活流感疫苗(TIV)的保护效果(VE)。方法运用前瞻性队列研究设计,招募接种和未接种TIV的≥60岁社区老年人随访6个月,观察流感样疾病(ILI)、因ILI就诊、因ILI或肺炎住院、因呼吸或循环系统疾病住院4种临床结局,计算TIV的VE。结果 TIV接种组、未接种组分别纳入研究对象1 048名、1 025名。接种TIV后1-3月预防4种临床结局的VE(95%CI)分别为-25.1(-80.4-13.2)%、-33.1(-99.2-11.1)%、35.8(-124.9-81.7)%和-12.6(-229.2-61.5)%;接种TIV后4-6月分别为25.5(-7.5-48.4)%、35.1(3.0-56.5)%、1.4(-249.1-72.1)%和-11.5(-240.9-63.5)%;接种TIV后1-6月分别为5.9(-24.2-28.7)%、11.6(-18.9-34.3)%、21.7(-99.2-69.2)%和-13.9(-155.5-49.2)%。结论台州市2018/2019年度社区老年人接种TIV对预防ILI病例发病、就诊和相关住院具有一定的保护效果。 相似文献
92.
Sina Schwarzkopf Adalbert Krawczyk Dietmar Knop Hannes Klump Andreas Heinold Falko M. Heinemann Laura Thümmler Christian Temme Marianne Breyer Oliver Witzke Ulf Dittmer Veronika Lenz Peter A. Horn Monika Lindemann 《Emerging infectious diseases》2021,27(1):122
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells. 相似文献
93.
Sarah A. Collier Li Deng Elizabeth A. Adam Katharine M. Benedict Elizabeth M. Beshearse Anna J. Blackstock Beau B. Bruce Gordana Derado Chris Edens Kathleen E. Fullerton Julia W. Gargano Aimee L. Geissler Aron J. Hall Arie H. Havelaar Vincent R. Hill Robert M. Hoekstra Sujan C. Reddy Elaine Scallan Erin K. Stokes Jonathan S. Yoder Michael J. Beach 《Emerging infectious diseases》2021,27(1):140
Provision of safe drinking water in the United States is a great public health achievement. However, new waterborne disease challenges have emerged (e.g., aging infrastructure, chlorine-tolerant and biofilm-related pathogens, increased recreational water use). Comprehensive estimates of the health burden for all water exposure routes (ingestion, contact, inhalation) and sources (drinking, recreational, environmental) are needed. We estimated total illnesses, emergency department (ED) visits, hospitalizations, deaths, and direct healthcare costs for 17 waterborne infectious diseases. About 7.15 million waterborne illnesses occur annually (95% credible interval [CrI] 3.88 million–12.0 million), results in 601,000 ED visits (95% CrI 364,000–866,000), 118,000 hospitalizations (95% CrI 86,800–150,000), and 6,630 deaths (95% CrI 4,520–8,870) and incurring US $3.33 billion (95% CrI 1.37 billion–8.77 billion) in direct healthcare costs. Otitis externa and norovirus infection were the most common illnesses. Most hospitalizations and deaths were caused by biofilm-associated pathogens (nontuberculous mycobacteria, Pseudomonas, Legionella), costing US $2.39 billion annually. 相似文献
94.
Md R. Rahaman Karen A. Alroy Chris A. Van Beneden Michael S. Friedman Erin D. Kennedy Mahmudur Rahman Arunmozhi Balajee A.K.M. Muraduzzaman Tahmina Shirin Meerjady S. Flora Eduardo Azziz-Baumgartner 《Emerging infectious diseases》2021,27(1):324
In April 2017, surveillance detected a surge in severe acute respiratory infections (SARI) in Bangladesh. We collected specimens from SARI patients and asymptomatic controls for analysis with multipathogen diagnostic tests. Influenza A(H1N1)pdm09 was associated with the SARI epidemic, suggesting that introducing vaccines and empiric antiviral drugs could be beneficial. 相似文献
95.
Tony Wawina-Bokalanga Bert Vanmechelen Valentine Lhermitte Joan Martí-Carreras Valentijn Vergote Fara Raymond Koundouno Joseph Akoi-Bor Ruth Thom Tom Tipton Kimberley Steeds Kita Balla Moussa Ablam Amento Lies Laenen Sophie Duraffour Martin Gabriel Paula Ruibal Yper Hall Mandy Kader-Kond Stephan Günther Guy Baele Cesar Muoz-Fontela Johan Van Weyenbergh Miles W. Carroll Piet Maes 《Emerging infectious diseases》2021,27(1):76
We investigated the genetic profiles of killer cell immunoglobulin-like receptors (KIRs) in Ebola virus–infected patients. We studied the relationship between KIR–human leukocyte antigen (HLA) combinations and the clinical outcomes of patients with Ebola virus disease (EVD). We genotyped KIRs and HLA class I alleles using DNA from uninfected controls, EVD survivors, and persons who died of EVD. The activating 2DS4–003 and inhibitory 2DL5 genes were significantly more common among persons who died of EVD; 2DL2 was more common among survivors. We used logistic regression analysis and Bayesian modeling to identify 2DL2, 2DL5, 2DS4–003, HLA-B-Bw4-Thr, and HLA-B-Bw4-Ile as probably having a significant relationship with disease outcome. Our findings highlight the importance of innate immune response against Ebola virus and show the association between KIRs and the clinical outcome of EVD. 相似文献
96.
Kenneth Siu-Sing Leung Timothy Ting-Leung Ng Alan Ka-Lun Wu Miranda Chong-Yee Yau Hiu-Yin Lao Ming-Pan Choi Kingsley King-Gee Tam Lam-Kwong Lee Barry Kin-Chung Wong Alex Yat Man Ho Kam-Tong Yip Kwok-Cheung Lung Raymond Wai-To Liu Eugene Yuk-Keung Tso Wai-Shing Leung Man-Chun Chan Yuk-Yung Ng Kit-Man Sin Kitty Sau-Chun Fung Sandy Ka-Yee Chau Wing-Kin To Tak-Lun Que David Ho-Keung Shum Shea Ping Yip Wing Cheong Yam Gilman Kit-Hang Siu 《Emerging infectious diseases》2021,27(1):196
Initial cases of coronavirus disease in Hong Kong were imported from mainland China. A dramatic increase in case numbers was seen in February 2020. Most case-patients had no recent travel history, suggesting the presence of transmission chains in the local community. We collected demographic, clinical, and epidemiologic data from 50 patients, who accounted for 53.8% of total reported case-patients as of February 28, 2020. We performed whole-genome sequencing to determine phylogenetic relationship and transmission dynamics of severe acute respiratory syndrome coronavirus 2 infections. By using phylogenetic analysis, we attributed the community outbreak to 2 lineages; 1 harbored a common mutation, Orf3a-G251V, and accounted for 88.0% of the cases in our study. The estimated time to the most recent common ancestor of local coronavirus disease outbreak was December 24, 2019, with an evolutionary rate of 3.04 × 10−3 substitutions/site/year. The reproduction number was 1.84, indicating ongoing community spread. 相似文献
97.
Pyoeng Gyun Choe Chang Kyung Kang Hyeon Jeong Suh Jongtak Jung Kyoung-Ho Song Ji Hwan Bang Eu Suk Kim Hong Bin Kim Sang Won Park Nam Joong Kim Wan Beom Park Myoung-don Oh 《Emerging infectious diseases》2021,27(1):327
We investigated the kinetics of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in 7 asymptomatic persons and 11 patients with pneumonia. The geometric mean titer of neutralizing antibodies declined from 219.4 at 2 months to 143.7 at 5 months after infection, indicating a waning antibody response. 相似文献
98.
Andrea Calcagno Valeria Ghisetti Teresa Emanuele Mattia Trunfio Silvia Faraoni Lucio Boglione Elisa Burdino Sabrina Audagnotto Filippo Lipani Marco Nigra Antonio DAvolio Stefano Bonora Giovanni Di Perri 《Emerging infectious diseases》2021,27(1):303
We measured severe acute respiratory syndrome coronavirus 2 spike protein subunits S1/S2 antibodies by using capillary electrophoresis and a chemiluminescence immunoassay for 5,444 active healthcare workers in Italy. Seroprevalence was 6.9% and higher among participants having contact with patients. Seroconversion was not observed in 37/213 previously infected participants. 相似文献
99.
Fabian Heinrich Kira Meißner Felicia Langenwalder Klaus Püschel Dominik Nrz Armin Hoffmann Marc Lütgehetmann Martin Aepfelbacher Eric Bibiza-Freiwald Susanne Pfefferle Axel Heinemann 《Emerging infectious diseases》2021,27(1):329
Analyses of infection chains have demonstrated that severe acute respiratory syndrome coronavirus 2 is highly transmissive. However, data on postmortem stability and infectivity are lacking. Our finding of nasopharyngeal viral RNA stability in 79 corpses showed no time-dependent decrease. Maintained infectivity is supported by virus isolation up to 35 hours postmortem. 相似文献
100.
Catherine A. Hogan ChunHong Huang Malaya K. Sahoo Hannah Wang Becky Jiang Mamdouh Sibai Marisa Holubar Roshni Mathew James Zehnder Benjamin A. Pinsky 《Emerging infectious diseases》2021,27(2):632
We developed an assay that detects minus-strand RNA as a surrogate for actively replicating severe acute respiratory syndrome coronavirus 2. We detected minus-strand RNA in 41 persons with coronavirus disease up to 30 days after symptom onset. This assay might inform clinical decision-making about patient infectiousness. 相似文献